Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

2.

A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis.

Jongjaroenprasert W, Phusantisampan T, Mahasirimongkol S, Mushiroda T, Hirankarn N, Snabboon T, Chanprasertyotin S, Tantiwong P, Soonthornpun S, Rattanapichart P, Mamanasiri S, Himathongkam T, Ongphiphadhanakul B, Takahashi A, Kamatani N, Kubo M, Nakamura Y.

J Hum Genet. 2012 May;57(5):301-4. doi: 10.1038/jhg.2012.20. Epub 2012 Mar 8.

PMID:
22399142
3.

Loss-of-function mutations in the thyrotropin receptor gene as a major determinant of hyperthyrotropinemia in a consanguineous community.

Tenenbaum-Rakover Y, Grasberger H, Mamanasiri S, Ringkananont U, Montanelli L, Barkoff MS, Dahood AM, Refetoff S.

J Clin Endocrinol Metab. 2009 May;94(5):1706-12. doi: 10.1210/jc.2008-1938. Epub 2009 Feb 24.

4.

Clinical and genetic characteristics of congenital hypothyroidism due to mutations in the thyroid peroxidase (TPO) gene in Israelis.

Tenenbaum-Rakover Y, Mamanasiri S, Ris-Stalpers C, German A, Sack J, Allon-Shalev S, Pohlenz J, Refetoff S.

Clin Endocrinol (Oxf). 2007 May;66(5):695-702. Epub 2007 Mar 23.

PMID:
17381485
5.

Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone.

Mamanasiri S, Yesil S, Dumitrescu AM, Liao XH, Demir T, Weiss RE, Refetoff S.

J Clin Endocrinol Metab. 2006 Sep;91(9):3471-7. Epub 2006 Jun 27.

PMID:
16804041

Supplemental Content

Loading ...
Write to the Help Desk